Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

EBR:CMBT - Euronext Brussels - BE0003816338 - Common Stock - Currency: EUR

7.69  +0.03 (+0.39%)

Fundamental Rating

4

Overall CMBT gets a fundamental rating of 4 out of 10. We evaluated CMBT against 61 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT has an excellent profitability rating, but there are concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
In the past year CMBT had a positive cash flow from operations.
Of the past 5 years CMBT 4 years were profitable.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.31%, CMBT belongs to the top of the industry, outperforming 90.16% of the companies in the same industry.
CMBT has a better Return On Equity (79.11%) than 98.36% of its industry peers.
CMBT has a worse Return On Invested Capital (5.06%) than 62.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMBT is below the industry average of 13.73%.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.06%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

With an excellent Profit Margin value of 72.50%, CMBT belongs to the best of the industry, outperforming 98.36% of the companies in the same industry.
CMBT's Profit Margin has improved in the last couple of years.
CMBT's Operating Margin of 35.88% is amongst the best of the industry. CMBT outperforms 80.33% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
CMBT's Gross Margin of 58.65% is fine compared to the rest of the industry. CMBT outperforms 67.21% of its industry peers.
CMBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMBT is still creating some value.
CMBT has less shares outstanding than it did 1 year ago.
CMBT has less shares outstanding than it did 5 years ago.
CMBT has a worse debt/assets ratio than last year.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.66. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CMBT (0.66) is worse than 80.33% of its industry peers.
CMBT has a Debt/Equity ratio of 3.75. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.75, CMBT is doing worse than 93.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACC0.69
WACC7.34%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.77 indicates that CMBT may have some problems paying its short term obligations.
CMBT's Current ratio of 0.77 is on the low side compared to the rest of the industry. CMBT is outperformed by 90.16% of its industry peers.
A Quick Ratio of 0.70 indicates that CMBT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, CMBT is doing worse than 90.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -79.01% in the last year.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
The Revenue for CMBT has decreased by -20.34% in the past year. This is quite bad
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%

3.2 Future

Based on estimates for the next years, CMBT will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.06% on average per year.
CMBT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.43% yearly.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year31.15%
Revenue Next 2Y28.49%
Revenue Next 3Y26.43%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

CMBT is valuated cheaply with a Price/Earnings ratio of 7.25.
Compared to the rest of the industry, the Price/Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 83.61% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.73, CMBT is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.36, the valuation of CMBT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 90.16% of the companies listed in the same industry.
CMBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.61.
Industry RankSector Rank
PE 7.25
Fwd PE 5.36
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.57% of the companies in the same industry are cheaper than CMBT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.53
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -29.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

0

5. Dividend

5.1 Amount

CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (8/12/2025, 5:29:32 PM)

7.69

+0.03 (+0.39%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-28 2025-08-28/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.69B
Analysts78
Price Target10.71 (39.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.88
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-6.61%
PT rev (3m)-12.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)22.4%
Revenue NY rev (3m)22.4%
Valuation
Industry RankSector Rank
PE 7.25
Fwd PE 5.36
P/S 1.41
P/FCF N/A
P/OCF 7.32
P/B 1.54
P/tB 1.8
EV/EBITDA 10.53
EPS(TTM)1.06
EY13.78%
EPS(NY)1.43
Fwd EY18.65%
FCF(TTM)-3.68
FCFYN/A
OCF(TTM)1.05
OCFY13.65%
SpS5.46
BVpS5.01
TBVpS4.27
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.06%
ROICexc 5.18%
ROICexgc 5.31%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.66
F-Score2
WACC7.34%
ROIC/WACC0.69
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year31.15%
Revenue Next 2Y28.49%
Revenue Next 3Y26.43%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%